Gut Microbiota and Critical Metabolites: Potential Target in Preventing Gestational Diabetes Mellitus?
- 2023-06-30
- Microorganisms 11(7)
- Runan Hu
- Zhuo Liu
- Yuli Geng
- Yanjing Huang
- Fan Li
- Haoxu Dong
- Wenwen Ma
- Kunkun Song
- Mingmin Zhang
- Yufan Song
- PubMed: 37512897
- DOI: 10.3390/microorganisms11071725
Gestational diabetes mellitus (GDM) is an intractable issue that negatively impacts the quality of pregnancy. The incidence of GDM is on the rise, becoming a major health burden for both mothers and children. However, the specific etiology and pathophysiology of GDM remain unknown. Recently, the importance of gut microbiota and related metabolic molecules has gained prominence. Studies have indicated that women with GDM have significantly distinct gut microbiota and gut metabolites than healthy pregnant women. Given that the metabolic pathways of gut flora and related metabolites have a substantial impact on inflammation, insulin signaling, glucose, and lipid metabolism, and so on, gut microbiota or its metabolites, such as short-chain fatty acids, may play a significant role in both pathogenesis and progression of GDM. Whereas the role of intestinal flora during pregnancy is still in its infancy, this review aims to summarize the effects and mechanisms of gut microbiota and related metabolic molecules involved in GDM, thus providing potential intervention targets.
Research Insights
| Supplement | Health Outcome | Effect Type | Effect Size |
|---|---|---|---|
| Lactobacillus salivarius UCC118 | No Human Health Outcome Reported | Neutral | Small |
| Lactobacillus salivarius UCC118 | No Reported Health Outcome | Neutral | Small |